SEC Filings for Novartis AG (NVS)

$ 92.07   0.43 (+0.47%) Volume: 951.44k 6:30 PM EST Dec 6, 2019
Filing Type:
Form TypeForm DescriptionPagesDateView
SC TO-TTender offer statement by Third Party15312/05/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934512/05/2019
SC TO-CWritten communication relating to an issuer or third party1811/25/2019
SC TO-CWritten communication relating to an issuer or third party4111/25/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934811/25/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934711/15/2019
4Statement of changes in beneficial ownership of securities111/12/2019
3Initial statement of beneficial ownership of securities211/06/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934611/01/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934610/30/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934310/22/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934710/08/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934610/02/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934709/30/2019
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934609/17/2019
<<
First
<
Prev
123456789101112131415